Comorbidity and dementia: A nationwide survey in Taiwan

Ting-Bin Chen, Szu-Yu Yiao, Yu Sun, Huey-Jane Lee, Shu-Chien Yang, Ming-Jang Chiu, Ta-Fu Chen, Ker-Neng Lin, Li-Yu Tang, Chung-Chih Lin, Pei-Ning Wang, Ting-Bin Chen, Szu-Yu Yiao, Yu Sun, Huey-Jane Lee, Shu-Chien Yang, Ming-Jang Chiu, Ta-Fu Chen, Ker-Neng Lin, Li-Yu Tang, Chung-Chih Lin, Pei-Ning Wang

Abstract

Background: Comorbid medical diseases are highly prevalent in the geriatric population, imposing hardship on healthcare services for demented individuals. Dementia also complicates clinical care for other co-existing medical conditions. This study investigated the comorbidities associated with dementia in the elderly population aged 65 years and over in Taiwan.

Methods: We conducted a nationwide, population-based, cross-sectional survey; participants were selected by computerized random sampling from all 19 Taiwan counties between December 2011 and March 2013. After exclusion of incomplete or erroneous data, 8,456 subjects were enrolled. Of them, 6,183 were cognitively normal (control group), 1,576 had mild cognitive impairment (MCI), and 697 had dementia. We collected information about types of comorbidities (i.e., vascular risk factors, lung diseases, liver diseases, gastrointestinal diseases, and cancers), Charlson comorbidity index score, and demographic variables to compare subjects with normal cognition, MCI, and dementia.

Results: Regardless of the cognitive condition, over 60% of the individuals in each group had at least one comorbid disease. The proportion of subjects possessing at least three comorbidities was higher in those with cognitive impairment (MCI 20.9%, dementia 27.3%) than in control group (15%). Hypertension and diabetes mellitus were the most common comorbidities. The mean number of comorbidities and Charlson comorbidity index score were greater in MCI and dementia groups than in control group. Logistic regression demonstrated that the comorbidities significantly associated with MCI and dementia were cerebrovascular disease (OR 3.35, CI 2.62-4.28), cirrhosis (OR 3.29, CI 1.29-8.41), asthma (OR 1.56, CI 1.07-2.27), and diabetes mellitus (OR 1.24, CI 1.07-1.44).

Conclusion: Multiple medical comorbid diseases are common in older adults, especially in those with cognitive impairment. Cerebrovascular disease, cirrhosis, asthma, and diabetes mellitus are important contributors to cognitive deterioration in the elderly. Efforts to lower cumulative medical burden in the geriatric population may benefit cognitive function.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Chung SD, Liu SP, Sheu JJ, Lin CC, Lin HC, Chen CH. Increased healthcare service utilizations for patients with dementia: a population-based study. PLoS One. 2014;9(8):e105789 Epub 2014/08/27. PubMed Central PMCID: PMCPmc4144915. doi:
    1. Huang SS, Lee MC, Liao YC, Wang WF, Lai TJ. Caregiver burden associated with behavioral and psychological symptoms of dementia (BPSD) in Taiwanese elderly. Arch Gerontol Geriatr. 2012;55(1):55–9. Epub 2011/05/24. doi:
    1. Sun Y, Lee HJ, Yang SC, Chen TF, Lin KN, Lin CC, et al. A nationwide survey of mild cognitive impairment and dementia, including very mild dementia, in Taiwan. PLoS One. 2014;9(6):e100303 Epub 2014/06/19. PubMed Central PMCID: PMCPmc4062510. doi:
    1. Wu YT, Lee HY, Norton S, Chen C, Chen H, He C, et al. Prevalence studies of dementia in mainland china, Hong Kong and taiwan: a systematic review and meta-analysis. PLoS One. 2013;8(6):e66252 Epub 2013/06/19. PubMed Central PMCID: PMCPMC3679068. doi:
    1. Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2015;11(6):718–26. Epub 2015/06/06.
    1. Schubert CC, Boustani M, Callahan CM, Perkins AJ, Carney CP, Fox C, et al. Comorbidity profile of dementia patients in primary care: are they sicker? J Am Geriatr Soc. 2006;54(1):104–9. Epub 2006/01/20. doi:
    1. Sanderson M, Wang J, Davis DR, Lane MJ, Cornman CB, Fadden MK. Co-morbidity associated with dementia. Am J Alzheimers Dis Other Demen. 2002;17(2):73–8. Epub 2002/04/17. doi:
    1. Nash DT, Fillit H. Cardiovascular disease risk factors and cognitive impairment. Am J Cardiol. 2006;97(8):1262–5. Epub 2006/04/18. doi:
    1. Breteler MM, Claus JJ, Grobbee DE, Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ. 1994;308(6944):1604–8. Epub 1994/06/18. PubMed Central PMCID: PMCPmc2540432.
    1. Kloppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol. 2008;585(1):97–108. Epub 2008/04/09. doi:
    1. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997;277(10):813–7. Epub 1997/03/12.
    1. Lyketsos CG, Toone L, Tschanz J, Rabins PV, Steinberg M, Onyike CU, et al. Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County Study. Am J Geriatr Psychiatry. 2005;13(8):656–64. Epub 2005/08/09. doi:
    1. Maslow K. Dementia and serious coexisting medical conditions: a double whammy. Nurs Clin North Am. 2004;39(3):561–79. Epub 2004/08/28. doi:
    1. Liu HC, Fuh JL, Wang SJ, Liu CY, Larson EB, Lin KN, et al. Prevalence and subtypes of dementia in a rural Chinese population. Alzheimer Dis Assoc Disord. 1998;12(3):127–34. Epub 1998/10/15.
    1. Liu CK, Lai CL, Tai CT, Lin RT, Yen YY, Howng SL. Incidence and subtypes of dementia in southern Taiwan: impact of socio-demographic factors. Neurology. 1998;50(6):1572–9. Epub 1998/06/20.
    1. Wang PN, Wang SJ, Hong CJ, Liu TT, Fuh JL, Chi CW, et al. Risk factors for Alzheimer's disease: a case-control study. Neuroepidemiology. 1997;16(5):234–40. Epub 1997/01/01.
    1. Chen TF, Chiu MJ, Tang LY, Chiu YH, Chang SF, Su CL, et al. Institution type-dependent high prevalence of dementia in long-term care units. Neuroepidemiology. 2007;28(3):142–9. Epub 2007/05/10. doi:
    1. Fan LY, Sun Y, Lee HJ, Yang SC, Chen TF, Lin KN, et al. Marital Status, Lifestyle and Dementia: A Nationwide Survey in Taiwan. PLoS One. 2015;10(9):e0139154 Epub 2015/09/29. PubMed Central PMCID: PMCPmc4587383. doi:
    1. 郭乃文, 劉秀枝, 王珮芳, 徐道昌(1989) 中文版「簡短式智能評估」(MMSE) 之簡介. 臨床醫學月刊23: 39–42.
    1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2011;7(3):270–9. Epub 2011/04/26. PubMed Central PMCID: PMCPmc3312027.
    1. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83. Epub 1987/01/01.
    1. Formiga F, Fort I, Robles MJ, Riu S, Sabartes O, Barranco E, et al. Comorbidity and clinical features in elderly patients with dementia: differences according to dementia severity. J Nutr Health Aging. 2009;13(5):423–7. Epub 2009/04/25.
    1. Solomon A, Dobranici L, Kareholt I, Tudose C, Lazarescu M. Comorbidity and the rate of cognitive decline in patients with Alzheimer dementia. Int J Geriatr Psychiatry. 2011;26(12):1244–51. Epub 2011/04/19. doi:
    1. Duthie A, Chew D, Soiza RL. Non-psychiatric comorbidity associated with Alzheimer's disease. QJM. 2011;104(11):913–20. Epub 2011/07/20. doi:
    1. Sakurai H, Hanyu H, Kanetaka H, Sato T, Shimizu S, Hirao K, et al. Prevalence of coexisting diseases in patients with Alzheimer's disease. Geriatrics & gerontology international. 2010;10(2):216–7. Epub 2010/05/08.
    1. Park HK, Na DL, Han SH, Kim JY, Cheong HK, Kim SY, et al. Clinical characteristics of a nationwide hospital-based registry of mild-to-moderate Alzheimer's disease patients in Korea: a CREDOS (Clinical Research Center for Dementia of South Korea) study. J Korean Med Sci. 2011;26(9):1219–26. Epub 2011/09/22. PubMed Central PMCID: PMCPmc3172661. doi:
    1. Stephan BC, Brayne C, Savva GM, Matthews FE. Occurrence of medical co-morbidity in mild cognitive impairment: implications for generalisation of MCI research. Age Ageing. 2011;40(4):501–7. Epub 2011/06/16. PubMed Central PMCID: PMCPmc3290328. doi:
    1. Artaz MA, Boddaert J, Heriche-Taillandier E, Dieudonne B, Verny M. [Medical comorbidity in Alzheimer's disease: baseline characteristics of the Cohort]. Rev Med Interne. 2006;27(2):91–7. Epub 2005/12/20. doi:
    1. Poblador-Plou B, Calderon-Larranaga A, Marta-Moreno J, Hancco-Saavedra J, Sicras-Mainar A, Soljak M, et al. Comorbidity of dementia: a cross-sectional study of primary care older patients. BMC Psychiatry. 2014;14:84 Epub 2014/03/22. PubMed Central PMCID: PMCPmc3994526. doi:
    1. Iadecola C, Gorelick PB. Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Stroke. 2003;34(2):335–7. Epub 2003/02/08.
    1. Picano E, Bruno RM, Ferrari GF, Bonuccelli U. Cognitive impairment and cardiovascular disease: so near, so far. Int J Cardiol. 2014;175(1):21–9. Epub 2014/05/27. doi:
    1. Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80(4):844–66. Epub 2013/11/26. PubMed Central PMCID: PMCPMC3842016. doi:
    1. Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011;7(3):137–52. Epub 2011/02/10. PubMed Central PMCID: PMCPMC3339565. doi:
    1. Li L, Holscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain research reviews. 2007;56(2):384–402. Epub 2007/10/09. doi:
    1. Prasad S, Sajja RK, Naik P, Cucullo L. Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview. Journal of pharmacovigilance. 2014;2(2):125-. PubMed Central PMCID: PMCPMC4306190. doi:
    1. Blazquez E, Velazquez E, Hurtado-Carneiro V, Ruiz-Albusac JM. Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease. Front Endocrinol (Lausanne). 2014;5:161. Epub 2014/10/28. PubMed Central PMCID: PMCPMC4191295.
    1. Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ. An update on type 2 diabetes, vascular dementia and Alzheimer's disease. Exp Gerontol. 2012;47(11):858–64. Epub 2012/08/14. doi:
    1. Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology. 2009;50(6):2014–21. Epub 2009/09/30. doi:
    1. Solinas A, Piras MR, Deplano A. Cognitive dysfunction and hepatitis C virus infection. World journal of hepatology. 2015;7(7):922–5. Epub 2015/05/09. PubMed Central PMCID: PMCPmc4419096. doi:
    1. Peng YH, Wu BR, Su CH, Liao WC, Muo CH, Hsia TC, et al. Adult asthma increases dementia risk: a nationwide cohort study. J Epidemiol Community Health. 2015;69(2):123–8. Epub 2014/10/02. doi:
    1. Chen MH, Li CT, Tsai CF, Lin WC, Chang WH, Chen TJ, et al. Risk of dementia among patients with asthma: a nationwide longitudinal study. J Am Med Dir Assoc. 2014;15(10):763–7. Epub 2014/07/20. doi:
    1. Dodd JW. Lung disease as a determinant of cognitive decline and dementia. Alzheimers Res Ther. 2015;7(1):32 Epub 2015/03/24. PubMed Central PMCID: PMCPmc4369069. doi:
    1. Duron E, Hanon O. Hypertension, cognitive decline and dementia. Arch Cardiovasc Dis. 2008;101(3):181–9. Epub 2008/05/15.
    1. Kahonen-Vare M, Brunni-Hakala S, Lindroos M, Pitkala K, Strandberg T, Tilvis R. Left ventricular hypertrophy and blood pressure as predictors of cognitive decline in old age. Aging Clin Exp Res. 2004;16(2):147–52. Epub 2004/06/16.
    1. Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia. Vascular health and risk management. 2008;4(2):363–81. Epub 2008/06/20. PubMed Central PMCID: PMCPmc2496986.
    1. Panza F, D'Introno A, Colacicco AM, Capurso C, Pichichero G, Capurso SA, et al. Lipid metabolism in cognitive decline and dementia. Brain research reviews. 2006;51(2):275–92. Epub 2006/01/18. doi:

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner